Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Non-Current Deffered Revenue (2016 - 2025)

Historic Non-Current Deffered Revenue for HUTCHMED (China) (HCM) over the last 10 years, with Q2 2025 value amounting to $30.8 million.

  • HUTCHMED (China)'s Non-Current Deffered Revenue fell 4922.06% to $30.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $30.8 million, marking a year-over-year decrease of 4922.06%. This contributed to the annual value of $190000.0 for FY2022, which is N/A changed from last year.
  • Latest data reveals that HUTCHMED (China) reported Non-Current Deffered Revenue of $30.8 million as of Q2 2025, which was down 4922.06% from $60.6 million recorded in Q2 2024.
  • HUTCHMED (China)'s 5-year Non-Current Deffered Revenue high stood at $97.2 million for Q2 2023, and its period low was $190000.0 during Q4 2022.
  • Moreover, its 4-year median value for Non-Current Deffered Revenue was $45.7 million (2024), whereas its average is $47.2 million.
  • As far as peak fluctuations go, HUTCHMED (China)'s Non-Current Deffered Revenue tumbled by 3761.32% in 2024, and later tumbled by 4922.06% in 2025.
  • Quarter analysis of 4 years shows HUTCHMED (China)'s Non-Current Deffered Revenue stood at $190000.0 in 2022, then soared by 51045.26% to $97.2 million in 2023, then tumbled by 37.61% to $60.6 million in 2024, then tumbled by 49.22% to $30.8 million in 2025.
  • Its Non-Current Deffered Revenue stands at $30.8 million for Q2 2025, versus $60.6 million for Q2 2024 and $97.2 million for Q2 2023.